{"version":"1.0","provider_name":"Institute of Infection","provider_url":"https:\/\/blogs.imperial.ac.uk\/institute-of-infection","author_name":"Natasha Khaleeq","author_url":"https:\/\/blogs.imperial.ac.uk\/institute-of-infection\/author\/nk1515\/","title":"AMR: Drug Resistance - In conversation with Dr Frances Davies and Dr Elita Jauneikaite - Institute of Infection","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"dglCVm6CU3\"><a href=\"https:\/\/blogs.imperial.ac.uk\/institute-of-infection\/2023\/11\/21\/amr-drug-resistance\/\">AMR: Drug Resistance &#8211; In conversation with Dr Frances Davies and Dr Elita Jauneikaite<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/blogs.imperial.ac.uk\/institute-of-infection\/2023\/11\/21\/amr-drug-resistance\/embed\/#?secret=dglCVm6CU3\" width=\"600\" height=\"338\" title=\"&#8220;AMR: Drug Resistance &#8211; In conversation with Dr Frances Davies and Dr Elita Jauneikaite&#8221; &#8212; Institute of Infection\" data-secret=\"dglCVm6CU3\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/blogs.imperial.ac.uk\/institute-of-infection\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"&nbsp; Antimicrobial resistance (AMR) is when bacterial, viral,\u00a0parasitic and fungal\u00a0infections\u00a0evolve so that they\u00a0no longer respond to existing treatments,\u00a0which has major impact on our ability to\u00a0combat\u00a0disease. Resistance to even one antibiotic can mean serious, with the\u00a0use of\u00a0second-line\u00a0and third-line treatments\u00a0potentially\u00a0harming\u00a0patients by causing serious side effects such as organ failure and prolonging\u00a0care and recovery.\u00a0When infections are resistant to [&hellip;]","thumbnail_url":"http:\/\/blogs.imperial.ac.uk\/institute-of-infection\/files\/2023\/11\/FDEJ-300x188.png"}